Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0N0ES
|
|||
Former ID |
DAP001546
|
|||
Drug Name |
Vitamin B3
|
|||
Synonyms |
Niacin (TN); Niacinamide (TN); Nicotinamide (TN)
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Lipid metabolism disorder [ICD-11: 5C52.Z] | Approved | [1] | |
Company |
Anmar
|
|||
Structure |
Download2D MOL |
|||
Formula |
C6H5NO2
|
|||
Canonical SMILES |
C1=CC(=CN=C1)C(=O)O
|
|||
InChI |
1S/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9)
|
|||
InChIKey |
PVNIIMVLHYAWGP-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 59-67-6
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:15940
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Diacylglycerol O-acyltransferase 2 (DGAT2) | Target Info | Inhibitor | [1] |
Nicotinic acid receptor (HCAR2) | Target Info | Agonist | [1] | |
BioCyc | Triacylglycerol biosynthesis | |||
KEGG Pathway | Glycerolipid metabolism | |||
Metabolic pathways | ||||
Fat digestion and absorption | ||||
Reactome | Acyl chain remodeling of DAG and TAG | |||
Triglyceride Biosynthesis | ||||
WikiPathways | Triacylglyceride Synthesis | |||
Glycerophospholipid biosynthesis | ||||
Fatty acid, triacylglycerol, and ketone body metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | Hakozaki T, Minwalla L, Zhuang J, Chhoa M, Matsubara A, Miyamoto K, Greatens A, Hillebrand GG, Bissett DL, Boissy RE: The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol. 2002 Jul;147(1):20-31. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.